Wednesday Jul 16
Cramer's Lightning Round - General Electric Needs To Bring Good Things To Life
Merck , Bristol Myers , Johnson & Johnson : "I would rather see you in Merck or Bristol Myers .
VIVUS Upgraded to Outperform by Zacks
The firm currently has a $5.70 price target on the stock. Zacks 's price target would indicate a potential upside of 7.55% from the stock's previous close.
The Motley Fool
FDA Drops the Hammer on Twitter
The FDA just announced new regulations for pharma and biotech companies that wish to promote their drugs via Twitter .
The Anti-Obesity Space Is Not As Simple As Some Think
When we look at the developing anti-obesity space, we often think of Vivus , Arena Pharmaceuticals , and Orexigen .
Okay, so good morning, everybody. My name is Matthew Andrews. I am a biotechnology analyst here at Wells Fargo.